Photos

An Indian employee from Cadila Pharmaceuticals Limited weighs Risorine capsules at its manufacturing facility on World Tuberculosis (TB) Day in Dholka, some 40 kms from Ahmedabad on March 24, 2015 Risorine, which uses lesser doses of anti-TB drug Rifampicin but with higher efficacy developed indigenously by Indian scientists, could cut short the duration of TB treatment. The World Health Organization has included India on the list of high-burdened countries that contribute to 80 percent of the world's TB problem. AFP PHOTO / Sam PANTHAKYSAM PANTHAKY/AFP/Getty Images